BRIEF published on 02/03/2026 at 12:17, 9 months 2 days ago GeNeuro SA bankrupt after the end of the composition moratorium Biopharmaceutical Bankruptcy GeNeuro Geneva Court Concordat Moratorium
BRIEF published on 02/03/2026 at 12:14, 9 months 2 days ago GeNeuro SA Declares Bankruptcy Following Debt Moratorium Biopharmaceutical Bankruptcy Court Ruling GeNeuro SA Debt Moratorium
PRESS RELEASE published on 02/03/2026 at 12:09, 9 months 2 days ago INSIDE INFORMATION / OTHER NEWS RELEASES GeNeuro SA announces the end of debt moratorium and commencement of bankruptcy proceedings after Geneva Court ruling. Further details in official publications Biopharmaceutical Company GeNeuro SA Bankruptcy Proceedings Debt Moratorium Geneva Court Ruling
BRIEF published on 01/23/2026 at 11:05, 9 months 13 days ago GeNeuro SA Suspends Trading Ahead of Court Ruling Euronext Paris Trading Suspension GeNeuro Debt Moratorium Geneva Court
BRIEF published on 01/23/2026 at 11:05, 9 months 13 days ago Temporary suspension of trading of GeNeuro SA shares on Euronext Paris Restructuring GeNeuro SA Geneva Court Trading Suspended Concordat Moratorium
PRESS RELEASE published on 01/23/2026 at 11:00, 9 months 13 days ago Inside Information / Other news releases GeNeuro SA requests temporary suspension of trading on Euronext Paris pending Geneva Court judgment on debt moratorium. Details on debt restructuring and impact on operations Euronext Paris GeNeuro SA Swiss Law Temporary Suspension Debt Moratorium
BRIEF published on 10/15/2025 at 20:30, 1 year ago GeNeuro Delays Half-Year Financial Report Release Financial Report Restructuring Biopharmaceutical GeNeuro Debt Moratorium
PRESS RELEASE published on 10/15/2025 at 20:25, 1 year ago Inside Information / Other news releases GeNeuro SA postpones the publication of June 30, 2025 half-yearly financial report to assess financial impacts of debt-restructuring moratorium extension. New date to be announced Financial Report Postponement Neurological Disorders GeNeuro SA Debt-restructuring Moratorium
BRIEF published on 09/26/2025 at 18:41, 1 year 1 month ago GeNeuro SA: Extension of the debt restructuring stay until 2026 Restructuring GeNeuro Neurological Diseases Composition Stay Geneva Court
PRESS RELEASE published on 09/26/2025 at 18:36, 1 year 1 month ago Inside Information / Other news releases GeNeuro SA extends its definitive debt-restructuring moratorium until January 27, 2026, to explore strategic options and continue developing treatments for neurodegenerative and autoimmune diseases Autoimmune Diseases GeNeuro SA Neurodegenerative Diseases Debt-restructuring Moratorium
Published on 11/06/2026 at 05:15, 1 hour 38 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 6 hours ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 6 hours 8 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/05/2026 at 23:20, 7 hours 33 minutes ago Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Published on 11/06/2026 at 06:45, 8 minutes ago Krones reports moderate growth and improved profitability in a challenging market environment
Published on 11/06/2026 at 04:55, 1 hour 58 minutes ago Segway Powersports Strengthens European Dealer Partnerships at EICMA 2026
Published on 11/06/2026 at 04:15, 2 hours 38 minutes ago Geely’s i-HEV Intelligent Hybrid Technology Offers a New Direction Vision for Gasoline-Powered Vehicles
Published on 11/06/2026 at 03:55, 2 hours 58 minutes ago Coway Announces Financial Results for Q3 FY2026
Published on 11/05/2026 at 18:21, 12 hours 31 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
Published on 11/05/2026 at 17:45, 13 hours 8 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 11/05/2026 at 17:29, 13 hours 23 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN FR0010406082
Published on 11/05/2026 at 10:16, 20 hours 36 minutes ago Growth acceleration confirmed in the third quarter of 2026 All businesses growing, revenue up +6,5%
